ArticleScientific reports2017

A novel orally bioavailable compound KPT-9274 inhibits PAK4, and blocks triple negative breast cancer tumor growth.

Chetan Rane et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.